Major depressive disorder criteria
Pro Research Analysisby 
Searched over 200M research papers
Major Depressive Disorder Criteria: An Overview
Diagnostic Criteria and Symptom Combinations
Symptom Combinations in MDD Diagnosis
Major Depressive Disorder (MDD) is characterized by a diverse range of symptom combinations. Research has identified 227 possible ways to meet the symptom criteria for MDD, though not all combinations are observed in clinical practice. In a study of over 1500 patients, 170 different symptom combinations were identified, with the most frequent being the presence of all nine criteria, accounting for 10.1% of cases. Notably, nine specific combinations accounted for over 40% of diagnoses, highlighting significant diagnostic heterogeneity within MDD .
Changes from DSM-IV to DSM-5
The transition from DSM-IV to DSM-5 introduced several changes to the diagnostic criteria for MDD. One notable change is the inclusion of hopelessness in the core mood criterion, potentially broadening the diagnosis. Additionally, the bereavement exclusion was replaced with a call for clinical judgment, complicating the distinction between normal grief and MDD. The DSM-5 also introduced new specifiers such as "with anxious distress" and "with mixed features," and expanded the "perinatal onset" specifier to include pregnancy .
Screening and Diagnostic Tools
PHQ-9 Screening Tool
The Patient Health Questionnaire (PHQ-9) is a widely used tool for screening MDD. A meta-analysis of 36 studies found that the PHQ-9 has acceptable diagnostic properties at a cutoff point of 10, with a pooled sensitivity of 0.78 and specificity of 0.87. The tool performs better in primary care settings compared to secondary care settings, emphasizing the need for context-specific diagnostic approaches .
Epidemiology and Clinical Guidelines
Prevalence and Impact in Canada
MDD affects approximately 11% of Canadians at some point in their lives, with a 4% prevalence in any given year. The disorder significantly impacts overall health, role functioning, and quality of life. Accurate detection and diagnosis remain challenging due to the heterogeneity of symptoms and the complexity of the disorder .
Subtypes and Biomarkers
Data-Driven Subtypes
Research into data-driven subtypes of MDD has identified various latent classes and factors, though findings are inconsistent. Most studies highlight a factor related to depressed mood and interest loss, often accompanied by psychomotor retardation or fatigue. However, the diversity of identified subtypes suggests either a lack of clear patterns or variability in theoretical and modeling approaches .
Genetic and EEG Biomarkers
Genome-wide association studies have identified 44 risk variants associated with MDD, implicating brain regions and genetic factors related to educational attainment, body mass, and schizophrenia. Additionally, EEG-based biomarkers have shown promise in distinguishing between depressed and healthy individuals, though further research is needed to establish causal links and improve diagnostic accuracy Greco2021Wray2017.
Conclusion
The diagnostic criteria for Major Depressive Disorder encompass a wide range of symptom combinations, reflecting the disorder's complexity and heterogeneity. Changes in diagnostic manuals, such as the DSM-5, and the development of screening tools like the PHQ-9, aim to improve diagnostic accuracy. Ongoing research into subtypes and biomarkers holds promise for refining our understanding and treatment of MDD, though challenges remain in achieving consensus and clinical applicability.
Sources and full results
Most relevant research papers on this topic